DUBLIN – (BUSINESS WIRE) – The report “Clinical Nutrition Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecast, 2021-2029” has been added ResearchAndMarkets.com to offer.
The growing geriatric population, the rising birth rate, the increase in the number of premature births and the increasing prevalence of malnutrition and chronic diseases are the main reasons for the growing demand for clinical nutrition. Malnutrition is a serious problem facing millions of people around the world, and clinical nutrition is the most effective way to treat malnutrition.
The increase in the incidence of cancer and other chronic diseases, as well as the number of surgical procedures, have increased the demand for enteral nutrition. The clinical nutrition market is expected to grow by 8% from 2019 to 2029. In addition, growing disposable income, health care spending, awareness and premature births will continue to increase demand for infant and child nutrition.
Key characters
-
Abbott Diet
-
B. Braun Melsungen AG
-
Fresenius Kabi
-
Danone SA
-
GlaxoSmithKline
-
Hospira, Inc.
-
Nutricia North America
-
Mead Johnson Nutrition Company
-
Perrigo Company Plc
-
Lonza, Ltd.
Pediatric nutrition will continue to dominate
Based on the nutrition types, the global clinical nutrition market for pediatric nutrition, enteral nutrition, and parenteral nutrition is studied. Among these, pediatric nutrition has the largest market share in 2016 (50.6%) and the segment will maintain its dominance over the forecast period. The high birth rate in the developed parts of the world and the increasing number of premature births mainly contribute to the leading position of this segment. On the other hand, the parenteral nutrition segment will see quite a higher growth over the forecast period. The significant increase in the prevalence of chronic diseases such as HIV / AIDS, diabetes, kidney failure, cancer and cardiovascular disease is the main reason for the growth of this segment (CAGR 4.5% in 2017-2025).
Metabolic disorders, eating disorders, developmental and recovery stages are the main medical conditions in which clinical nutrition is widely used. Currently, the recovery and development phase enjoys the leading position in terms of revenue share in the global clinical nutrition market. The dominance of this segment is mainly explained by the significant increase in the infant and pediatric patient pool, the strong growth in the number of patients with chronic diseases and the largest potential patient pool. However, with the steady increase in the discovery of immune system-associated metabolic diseases and the corresponding increase in the respective patient group in the forecast period, the metabolic diseases segment will occupy a clearly prominent position in the global market for clinical nutrition
The Asia-Pacific region is considered to be the most lucrative market
Geographically, the global clinical nutrition market is studied for North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. North America currently has the largest share of sales in the global clinical nutrition market. The dominance of this region is largely attributed to widespread awareness of the benefits of clinical nutrition, the large patient pool, and evolving reimbursement policies in both hospitals and home care locations. On the other hand, the Asia-Pacific region is considered to be the most lucrative clinical nutrition market due to rapid industrialization, developing education system, increasing disposable income, rapid development of health care and infrastructure.
Important questions answered in this report
-
What are the key market segments in the current scenario and in the future by product category?
-
What are the key market segments in the current scenario and in the future by region?
-
What are the key impact of Covid-19 on market revenue and market determinants in the Clinical Nutrition Market?
-
What are the primary and secondary macro and microfactors influencing market growth now and over the forecast period?
-
What are the primary and secondary macro and microfactors holding market growth now and over the forecast period?
-
How do you master the current market challenges and use the opportunities in each of the market segments?
-
Who are the key players in the Clinical Nutrition market and what are their key product categories and strategies?
-
What are the key strategies – mergers / acquisitions / R&D / strategic partnerships etc that companies are using to increase market revenue and growth?
Key topics covered:
Chapter 1 Preface
Chapter 2 Summary
Chapter 3 Clinical Nutrition: Market Dynamics and Outlook
3.1 Introduction, data and facts
3.2 Driver
3.3 Challenges
3.4 opportunities
3.5 Major Commercial Events
3.6 Attractive range of investments
3.1 Competitive Analysis: Clinical Nutrition by Key Market Players
Chapter 4 Global Clinical Nutrition Market by Nutrition Type
Chapter 5 Global Clinical Nutrition Market By Medical Condition
Chapter 6 Global Clinical Nutrition Market by End Use
Chapter 7 Global Clinical Nutrition Market by Geography
Chapter 8 Company Profiles
Please visit https://www.researchandmarkets.com/r/q18snm for more information on this report
